Purchase Order 75D30124P19390
- Not listed
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Twist Bioscience Corporation, a for-profit synthetic biology company, to provide TWIST RNA products for the FLUSC2 MULTIPLE program. The $51,160.00 contract does not have a set-aside designation and is scheduled for completion by April 30, 2024. Twist Bioscience, a manufacturer of goods, has previously received numerous federal contracts to supply synthetic...
- This $363,754.94 firm fixed price purchase order from the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) was awarded to Twist Bioscience Corporation, a synthetic biology company, to provide SC2 POSITIVE CONTROL SYNTHETIC RNA CONTROL. The contract does not have a set-aside designation. Twist Bioscience is a for-profit manufacturer based in South San Francisco, California that develops custom oligonucleotides, gene panels, and other synthetic biology...
- This firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The contract, valued at $578,224.78, is for the delivery of SC2 POSITIVE CONTROL SYNTHETIC RNA CONTROL MATERIAL. This contract is not associated with a set-aside program. Twist Bioscience has been awarded numerous federal contracts, primarily as a prime contractor, to provide synthetic DNA...
- This federal contract award was issued by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Twist Bioscience Corporation, a for-profit synthetic biology company based in South San Francisco, California. The $125,565.50 firm fixed price purchase order is for the delivery of SARS COV2 RNA control products to support COVID-19 research and diagnostics efforts. The contract does not have a set-aside designation. Twist Bioscience provides various...
- The Department of Health and Human Services Centers for Disease Control and Prevention (HHS CDC) awarded a firm fixed price purchase order contract to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The $220,065.50 contract is for the provision of SARS COV 2 RNA controls to support COVID-19 research efforts. Twist Bioscience, as a prime contractor, has provided various research products to federal agencies including the NIH, VA, and...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The $97,588 contract is for the provision of COVID-19 DNA constructs, which likely support genomics research, disease surveillance, and public health initiatives. This contract does not have a set-aside designation. Twist...
- This is a firm fixed price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Twist Bioscience Corporation, a for-profit synthetic biology company based in South San Francisco, California. The contract is for the provision of biological and reagent materials, with a ceiling value of $12,206.25 and a period of performance through September 4, 2025. There is no set-aside designation for this...
- This is a firm fixed price purchase order valued at $22,400.00 awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Twist Bioscience Corporation for DNA synthesis services to support gene cloning. The contract has no set-aside designation and the ultimate completion date is December 31, 2024. Twist Bioscience is a synthetic biology company that specializes in manufacturing high-quality synthetic DNA and has...
- This is a $14,031.25 firm fixed price purchase order awarded by the National Human Genome Research Institute (NHGRI) to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The contract is for Twist Bioscience to provide a custom capture panel to support a new blood-based cancer diagnostic that will detect human herpesvirus 8 (HHV8) in the plasma of HIV patients. The award has an ultimate completion date of October 31, 2024 and was made on August...
- Twist Bioscience Corporation has been awarded a firm fixed price purchase order contract valued at $24,285 by the National Institutes of Health's National Institute of Neurological Disorders and Stroke to provide a custom single site variant library. As the prime contractor, Twist Bioscience will deliver the requested synthetic DNA products to support genomics research efforts. No set aside designation was applied to this award. Twist Bioscience is a manufacturer of synthetic DNA based in...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $157,390 firm fixed price purchase order contract to Twist Bioscience Corporation for the delivery of "LAP SUPPLIES." This contract, which has a completion date of September 14, 2025, does not include a set-aside designation. Twist Bioscience is a synthetic biology company that specializes in the manufacture of high-quality synthetic DNA products and services. Through this contract, Twist Bioscience will likely provide the CDC's Pittsburgh location with various custom oligonucleotides, gene panels, RNA controls, and other synthetic biology tools to support the agency's genomics research, disease surveillance, and public health initiatives. In addition to this prime contract, Twist Bioscience has also been awarded federal grant sub-awards and served as a subcontractor on other government contracts, demonstrating its ability to leverage its synthetic biology expertise to address critical public health needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $157.4k | 7/25/24 |